Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.6% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.62% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
State Street Energy Select Sector SPDR ETF
XLE
$39B
| $12.1M | 0.02% |
359,464
+172,588
| +92% | +$6.11M |
|
|
DNR
1202
DELISTED
Denbury Resources, Inc.
DNR
| $12.1M | 0.02% |
4,416,547
+1,005,671
| +29% | +$2.37M |
|
1203
Avery Dennison
AVY
$13B
| $12.1M | 0.02% |
113,810
+32,287
| +40% | +$3.74M |
|
|
BECN
1204
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $12.1M | 0.02% |
227,827
-1,271,291
| -85% | -$73.1M |
|
|
CPE
1205
DELISTED
Callon Petroleum Company
CPE
| $12.1M | 0.02% |
91,288
+63,321
| +226% | +$7.43M |
|
|
ITCI
1206
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $12.1M | 0.02% |
573,968
-880,976
| -61% | -$17.2M |
|
|
APC
1207
CALL
DELISTED
Anadarko Petroleum
APC
| $12.1M | 0.02% |
+200,000
| New | +$11.7M |
|
1208
iShares Core S&P 500 ETF
IVV
$872B
| $12.1M | 0.02% |
45,484
-38,069
| -46% | -$10.5M |
|
|
CVG
1209
DELISTED
Convergys
CVG
| $12.1M | 0.02% |
533,322
+335,092
| +169% | +$7.68M |
|
1210
Provident Financial Services
PFS
$3.22B
| $12.1M | 0.02% |
471,294
+127,776
| +37% | +$3.36M |
|
|
AVEO
1211
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $12.1M | 0.02% |
415,609
+142,904
| +52% | +$4.18M |
|
|
TIVO
1212
DELISTED
Tivo Inc
TIVO
| $12M | 0.02% |
888,970
+316,946
| +55% | +$4.52M |
|
1213
Ionis Pharmaceuticals
IONS
$8.6B
| $12M | 0.02% |
272,837
+76,920
| +39% | +$3.91M |
|
|
EXTN
1214
DELISTED
Exterran Corporation
EXTN
| $12M | 0.02% |
450,273
+221,808
| +97% | +$6.42M |
|
|
TPIC
1215
DELISTED
TPI Composites
TPIC
| $12M | 0.02% |
534,255
-81,909
| -13% | -$1.68M |
|
1216
Exelon
EXC
$47.2B
| $12M | 0.02% |
430,710
-3,482,983
| -89% | -$94M |
|
1217
Koppers
KOP
$943M
| $12M | 0.02% |
291,279
+204,402
| +235% | +$8.99M |
|
|
INFN
1218
DELISTED
Infinera Corporation Common Stock
INFN
| $11.9M | 0.02% |
1,099,867
+1,001,790
| +1,021% | +$8.88M |
|
1219
Kulicke & Soffa
KLIC
$4.67B
| $11.9M | 0.02% |
477,382
-980,668
| -67% | -$23.6M |
|
|
KDNY
1220
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $11.9M | 0.02% |
256,469
+196,781
| +330% | +$7.2M |
|
|
WWE
1221
DELISTED
World Wrestling Entertainment
WWE
| $11.9M | 0.02% |
331,099
-556,505
| -63% | -$19.6M |
|
|
VIVO
1222
DELISTED
Meridian Bioscience Inc
VIVO
| $11.9M | 0.02% |
839,609
-294,156
| -26% | -$4.35M |
|
1223
Black Hills Corp
BKH
$5.42B
| $11.9M | 0.02% |
219,348
-268,083
| -55% | -$14.3M |
|
|
AVP
1224
DELISTED
Avon Products, Inc.
AVP
| $11.9M | 0.02% |
4,184,563
-4,650,955
| -53% | -$11.8M |
|
|
VISN
1225
Vistance Networks Inc
VISN
$2.65B
| $11.9M | 0.02% |
296,677
-26,100
| -8% | -$1.02M |
|
Similar funds
Millennium Management's Q1 2018 Portfolio in Review
As of Q1 2018, Millennium Management held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Millennium Management deployed $3.3B of net new capital in Q1 2018, opening 664 new positions and adding to 1,467 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Millennium Management's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Millennium Management added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Millennium Management's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Millennium Management fully exited Equinix in Q1 2018, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Millennium Management opened 664 new positions and closed 833 in Q1 2018.
- Millennium Management's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.